Skip to main content
FinSpry Logo
FinSpry
INMB logo
INMB
(NASDAQ)
INmune Bio Inc.
$1.21-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

INmune Bio (INMB) Stock Price & Financial Analysis

INmune Bio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.19 - $1.23
52-Week High$11.64
52-Week Low$1.09
Open$1.20
Volume322.97K
Average Volume (3M)322.97K
Market Cap32.17M
Shares Outstanding26.59M
Price to Sales (P/S)654.00
Price to Book (P/B)1.29
EV/EBITDA-0.19
Revenue (TTM)50.00K
Net Income (TTM)-49.89M
Free Cash Flow (TTM)-31.55M
EPS (TTM)$-1.88
Profit Margin-99774.00%
Operating Margin-69724.00%
Return on Equity (ROE)-196.58%
Debt to Equity0.06
50-Day MA$1.39
200-Day MA$2.06
52-Week Change-83.79%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About INmune Bio

What is the current stock price for INMB?

As of the latest trading session, INMB stock trades at $1.21. The 52-week range is $1.09–$11.64, with a day range of $1.19–$1.23.

What is the P/E ratio for INMB?

The P/E ratio (Price-to-Earnings) for INMB is shown in the Key Statistics section. This valuation metric helps compare INmune Bio Inc. to industry peers.

Does INMB pay dividends?

INmune Bio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for INMB?

Based on 1 analyst, the consensus for INMB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of INMB?

INmune Bio's market capitalization is $32.2M, classifying it as a micro-cap company. INmune Bio operates in the Healthcare sector within the Biotechnology industry.